United Therapeutics Corporation · NASDAQ:UTHR
Patusky Christopher sold 1,000 United Therapeutics Corporation shares (Form 4)
Traded Apr 17, 2026 · Filed Apr 17, 2026
On Apr 17, 2026, Patusky Christopher (Director) sold 1,000 United Therapeutics Corporation shares at US$578.88 for US$579K under a trading plan, leaving 1,490 shares. Filed Apr 17, 2026 (Form 4).
- Sold
- 1,000 shares
- Price
- US$578.88
- Value
- US$579K
- Holding after
- 1,490 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 17, 2026 | Common Stock | Option exercise | 1,000 | US$101.80 | 2,490 | Direct |
| Apr 17, 2026 | Common Stock | Sale | 1,000 | US$578.88 | 1,490 | Direct |
Source
Related
- United Therapeutics Corporation
- Patusky Christopher
- United Therapeutics Corporation shareholders
- Form 4 · Patusky Christopher · Jul 13, 2026
- Form 4 · Patusky Christopher · Apr 24, 2026
- Form 4 · Rothblatt Martine A · Oct 21, 2026
- Form 4 · Rothblatt Martine A · Oct 20, 2026
- Form 4 · Rothblatt Martine A · Oct 19, 2026
- Schedule 13G/A · Rothblatt Martine A · Aug 14, 2026
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026